D. Fière

发表

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis.

T. Tsuruo, D. Treille, E. Archimbaud, 1992, Blood.

Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.

G. Salles, B. Coiffier, H. Godinot, 2000, Experimental hematology.

Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, J. Reiffers, O. Ringdén, 1997, Transplantation proceedings.

Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy

X. Thomas, A. Thiébaut, E. Archimbaud, 1997, Annals of Hematology.

Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group.

E. Archimbaud, J. Extra, J. Sotto, 1987, Haematology and blood transfusion.

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL).

A. Delannoy, A. Bernheim, C. Bastard, 2004, Blood.

Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.

E. Thiel, P. Delmas, A. Sakalová, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults.

S. Suciu, Y. Benoît, G. Solbu, 1983, Blood.

Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group.

R. Willemze, C. Haanen, B. Löwenberg, 1989, Blood.

acute lymphoblastic leukemia in children and adults Comparison of chemotherapy with immunotherapy for maintenance of

S. Suciu, Y. Benoît, G. Solbu, 2011 .

Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome.

X. Thomas, E. Archimbaud, M. Joly, 1997, Leukemia & lymphoma.

Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α

C. Vigouroux, C. Dumontet, X. Thomas, 2000, Leukemia.

All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.

H. Dombret, A. Vekhoff, E. Wattel, 2002, The hematology journal : the official journal of the European Haematology Association.

Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission.

J. Magaud, R. Rimokh, X. Thomas, 1999, Hematology and cell therapy.

Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint

J. Magaud, R. Rimokh, X. Thomas, 1998, Leukemia.

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, J. Reiffers, O. Ringdén, 1996, Bone marrow transplantation.

Analysis of definitions used in clinical research on invasive fungal infections Consensus proposal for new, standardized definitions

D. Denning, J. Meis, J. Rex, 1999 .

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience

H. Dombret, E. Macintyre, T. Fest, 2006, Leukemia.

TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.

J. Cayuela, C. Bastard, B. Debuire, 1996, Leukemia.

Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemias.

B. Coiffier, E. Archimbaud, P. Bryon, 1986, Cancer treatment reports.

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.

P. Moreau, W. Bezwoda, P. Colombat, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia

X. Thomas, E. Archimbaud, D. Fière, 1998, Leukemia.

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

C. Sebban, X. Thomas, E. Archimbaud, 1992, Leukemia.

Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: preliminary results of an open French multicentre randomized study.

C. Charrin, G. Marit, P. Bernard, 1991, European journal of cancer.

In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes.

X. Thomas, L. Campos, D. Guyotat, 1991, Leukemia research.

Granulocyte colony‐stimulating factor given in addition to interferon‐α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia

P. Adeleine, C. Charrin, E. Archimbaud, 1997 .

Sequential Chemotherapy with Mitoxantrone, Etoposide and Cytarabine for Previously Treated Acute Myeloid Leukemia: EMA 86 Regimen

P. Fenaux, X. Thomas, X. Troussard, 1996 .

Prognostic Factors in Acute Promyelocytic Leukemia: A Retrospective Study of 67 Cases.

X. Thomas, E. Archimbaud, D. Fière, 1991, Leukemia & lymphoma.

Conventional Therapy in Adult Acute Lymphoblastic Leukemia: Review of the LALA Program

X. Thomas, D. Fière, D. Fiére, 2008 .

Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.

X. Thomas, A. Thiébaut, C. Charrin, 1998, Hematology and cell therapy.

Acute leukaemia following high-dose chemoradiotherapy with bone marrow rescue for ovarian teratoma.

B. Coiffier, D. Treille, E. Archimbaud, 1988, Acta haematologica.

Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.

H. Gerhartz, R. Marcus, H. Zwierzina, 1989, Bone marrow transplantation.

Myeloid surface antigen expression in adult acute lymphoblastic leukemia.

D. Treille, J. Magaud, C. Charrin, 1990, Leukemia.

Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.

C. Sebban, C. Charrin, L. Campos, 1996, Leukemia.

Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.

M. Laville, D. Fouque, C. Vigneau, 2002, Journal of nephrology.

Specific binding between human neutrophils and heparin

E. Archimbaud, A. Francina, Y. Lasne, 1992, British journal of haematology.

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).

F. Berger, B. Coiffier, J. Magaud, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlations between cytogenetics and morphology in myelodysplastic syndromes

C. Charrin, E. Archimbaud, P. Felman, 1990, Blut.

Hypodiploidy with 30-39 chromosomes and near-triploidy: two possible expressions of a sole entity conferring poor prognosis in Adult Acute Lymphoblastic Leukemia (ALL). A report from the LALA-94 and LALA-SA Groups

A. Bernheim, C. Bastard, L. Michaux, 2004 .

Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation

M. Dechavanne, M. Ffrench, P. Ffrench, 1994, European journal of haematology.